Pirfenidone and M-DDO Topical Composition for Multifactorial Acne
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Acne is a complex skin condition involving genetic, sebum production, keratinization, bacterial, and inflammatory factors, leading to lesions and scars, with existing treatments often focusing on single aspects rather than comprehensive management.
Innovation Solution
A semi-solid topical composition combining 8% pirfenidone and 0.016% modified diallyl disulfide oxide (M-DDO) is used to eliminate, reduce, or prevent acne by acting synergistically as an anti-inflammatory, antimicrobial, and antiseptic agent, modulating keratinocyte production, blocking pro-inflammatory cytokines, and inhibiting anaerobic bacterial growth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing acne treatments focus on single aspects (sebum production, keratinization, or bacterial growth), then the treatment mechanism is simple, but the effectiveness is limited due to acne's multifactorial nature
Solution Approach 1:
The patent combines three distinct acne treatment mechanisms into a single composition: pirfenidone addresses keratinization abnormalities and inflammation, while M-DDO targets bacterial growth and sebum production. This merging of multiple treatment approaches into one formulation resolves the contradiction by providing comprehensive acne management without requiring multiple separate treatments, thereby improving reliability while maintaining practical simplicity.
Solution Approach 2:
The invention uses a composite formulation containing both pirfenidone (an anti-inflammatory and keratinization-modulating agent) and M-DDO (an antimicrobial and sebum-regulating agent). This composite material approach allows the treatment to simultaneously address multiple acne pathogenic factors, resolving the contradiction between treatment effectiveness and mechanism complexity by integrating multiple functions into a unified therapeutic system.
2Reliability
If multiple acne treatment mechanisms are combined, then the treatment effectiveness improves, but the formulation complexity increases
Solution Approach 1:
The patent merges multiple treatment mechanisms into a single topical composition by combining pirfenidone and M-DDO in specific concentrations. This merging strategy achieves comprehensive acne management by simultaneously addressing keratinization, inflammation, bacterial growth, and sebum production, while maintaining formulation simplicity through a single-application product rather than requiring multiple separate treatments.
3Ease of operation
If conventional acne treatments are used, then the application is simple, but they fail to address all five primary pathogenic factors of acne
Solution Approach 1:
The patent creates a universal acne treatment formulation where pirfenidone provides anti-inflammatory and keratinization-modulating effects, while M-DDO delivers antimicrobial and sebum-regulating properties. This multi-functional composition allows a single application to address all five primary pathogenic factors of acne (genetic predisposition, sebum production, keratinization abnormalities, bacterial proliferation, and inflammation), thereby achieving comprehensive coverage without compromising application simplicity.
Data Source
AI summary
The instant invention relates to a semi-solid topical composition containing Pirfenidone and an antimicrobial/antiseptic agent such as Modified Diallyl Disulfide Oxide (M-DDO) and its preparation process, offering advantages compared to other pharmaceutical forms of topical administration known in the state of the art, useful as antifibrotic, anti-inflammatory and antiseptic agent in the prevention, treatment and reversion of acne and post acne lesions. Said compositions is also useful for reducing skin redness, detaining the formation of new acne outbreaks, reversing already existing outbreaks and regenerating skin damage caused by acne.